|Articles|February 1, 2004

LCGC North America

  • LCGC North America-02-01-2004
  • Volume 22
  • Issue 2

Investigating Out-of-Specification Results

This column discusses potential sources and ways to avoid out-of-specification (OOS) results and highlights the draft FDA guidelines on OOS investigations.


Related to this article

Sam Whitmarsh, Nitish Sharma, Piotr Alvarez, GLP-1 Peer Exchange
Meet the expert panel exploring the challenges involved in GLP-1 analysis in this LCGC International Peer Exchange®.
Chromatography Detects Toxins in Tea Samples
High-performance liquid chromatography-tandem mass spectroscopy (HPLC–MS/MS) chromatography reveals pyrrolizidine alkaloids (PA)/pyrrolizidine alkaloid N-oxides (PANO) toxin risks in 63 tea samples.